jcp conference-coverage

Conference Coverage

Videos

Optimizing Clinical Trials in Academia and Community Oncology

10/27/2022

Ira Klein, MD, discusses design in clinical trials, touching on current issues such as clinical workflow and operational processes, and the barriers to participating in a clinical trial in community oncology.

Ira Klein, MD, discusses design...

10/27/2022

Journal of Clinical Pathways

Conference Coverage

Optimal Utilization of Telehealth to Enhance Patient Care and Clinical Trial Participation

10/18/2022

Katie Herman ;

Craig Ostroff ;

Matthew A Lunning, DO, FACP, Associate Professor, Fred & Pamela Buffett Cancer Center, Associate Vice-Chair of Research Department of Medicine, Assistant Vice Chancellor of Clinical Research, University of Nebraska Medical Center, Omaha,...

Matthew A Lunning, DO, FACP,...

10/18/2022

Journal of Clinical Pathways

Conference Coverage

Just in Time Clinical Trials: A Solution for Both Academia and Community Oncology

10/18/2022

Craig Ostroff ;

At the 2022 Oncology Clinical Pathways Congress, Dr Ira Klein discussed the need to improve access and reach typically underrepresented populations in order to make clinical trials and cancer treatment studies more representative of the...

At the 2022 Oncology Clinical...

10/18/2022

Journal of Clinical Pathways

Conference Coverage

CancerLinQ Technology in the Oncology Community

10/17/2022

Katie Herman ;

Craig Ostroff ;

Robert S. Miller, MD, FACP, FASCO, FAMIA, Chief Medical Science Officer, CancerLinQ, American Society of Clinical Oncology, described how data aggregation and analytic platforms are aiding in clinical decision support and explained current...

Robert S. Miller, MD, FACP,...

10/17/2022

Journal of Clinical Pathways

Conference Coverage

ePROs Effect on Patient Health Outcomes

10/17/2022

Katie Herman ;

Craig Ostroff ;

Michael Kolodziej, MD, Senior Advisor, ADVI, presented that patient monitoring during treatment using electronic patient-reported outcomes significantly improves results.

Michael Kolodziej, MD, Senior...

10/17/2022

Journal of Clinical Pathways

Conference Coverage

Precision Medicine and AI in Oncology Patient Care

10/16/2022

Katie Herman ;

Craig Ostroff ;

Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.

Tushar Pandey, CEO, SimBioSys,...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Low-Value Care Directly Leads to Development of Cancer Genomic Pathways

10/16/2022

Katie Herman ;

Craig Ostroff ;

Tatjana Kolevska, MD, explains at the 2022 Oncology Clinical Pathways Conference that digital pathways are the way of the future in regard to cancer care.

Tatjana Kolevska, MD, explains...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Gene Sequencing in the Clinic

10/16/2022

Katie Herman ;

Craig Ostroff ;

Mahek Shah, MD, MBA, MS, at the 2022 Oncology Clinical Pathways Congress, discussed the need to enable gene sequencing-as-a-service in clinical settings and what that means for future clinical care.

Mahek Shah, MD, MBA, MS, at the...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Complex Diagnostic Imaging and the CMS Imaging AUC Program

10/16/2022

Katie Herman ;

Craig Ostroff ;

Elliot K Fishman, MD, FACR, Professor of Radiology, Oncology, Surgery and Urology, Johns Hopkins Hospital, presented at the 2022 Oncology Clinical Pathways Congress about Medicare’s Appropriate Use Criteria program and the challenges in...

Elliot K Fishman, MD, FACR,...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Integrating Social Determinants of Health

10/16/2022

Katie Herman ;

Craig Ostroff ;

At the 2022 Oncology Clinical Pathways Congress, Mishellene McKinney, MHA, RN, OCN, Vice President, Cancer Care Services, Kaiser Permanente; and Anand Shah, MD, MS, Vice President, Social Health, Kaiser Permanente, discussed the importance of...

At the 2022 Oncology Clinical...

10/16/2022

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

2024 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Update: Impact on NSCLC Landscape

11/15/2024

The updated 2024 NCCN Guidelines® recommend broad genomic testing and the need for multidisciplinary care to accurately diagnose and treat non-small cell lung cancer. View this special report to learn more.

The updated 2024 NCCN...

11/15/2024

Journal of Clinical Pathways

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Conference Coverage

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products